From: Prognostic value of brain natriuretic peptide in acute pulmonary embolism
Reference | BNP/NT-proBNP | Assay | Manufacturer | Kind of assay | Cutoff, pg/mL | Elevated BNP, percentage |
---|---|---|---|---|---|---|
Kucher, et al. [1] | BNP | Fluorescence immunoassay | Biosite (San Diego, USA) | Quantitative | 90 | 43.8 |
Ten Wolde, et al. [2] | BNP | Immunoradiometric assay | Shionoria (Osaka, Japan) | Quantitative | 21.7 | 33 |
Pieralli, et al. [3] | BNP | Fluorescence immunoassay | Biosite | Quantitative | 527 | 67 |
Krüger, et al. [4] | BNP | Immunofluorometric assay | Biosite | Quantitative | 90 | 40 |
Tulevski, et al. [5] | BNP | Immunoradiometric assay | Shionoria | Quantitative | 10 | 50 |
Logeart, et al. [6] | BNP | Fluorescence immunoassay | Biosite | Quantitative | 100 | 70 |
Ray, et al. [7] | BNP | Fluorescence immunoassay | BioMérieux (Marcy l'Etoile, France) | Quantitative | 200 | 43 |
Pruszczyk, et al. [8] | NT-proBNP | ECLIA | Roche (Basel, Switzerland) | Quantitative | NA | 83.5 |
Kucher, et al. [9] | NT-proBNP | ECLIA | Roche | Quantitative | 500 | 57 |
Kostrubiec, et al. [10] | NT-proBNP | ECLIA | Roche | Quantitative | 600 | 39 |
Binder, et al. [11] | NT-proBNP | ECLIA | Roche | Quantitative | 1,000 | 54 |
Maziere, et al. [12] | NT-proBNP | ECLIA | Roche | Quantitative | 1,000 | 43 |